Daily FNArena News

FNArena is one of few remaining truly independent providers of financial markets analysis, financial commentary and business news in Australia. Our Daily Financial News is not based on ASX lodgements or corporate press releases, but more so on updated views, insights and responses from stockbrokers and other experts. FNArena is not aligned with any financial institution, hence the moniker “independent”. We have a long history of publishing out-of-consensus views and market analysis. Our quest is not to be bullish or bearish, but to correctly assess future trends.

Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest |

Previous Stories

Global Trade And The Yuan

Oct 25 2011 - FYI

Ahead of the Herd’s Rick Mills suggests the global shift in trade and the growing importance of the Chinese yuan should be on the radar screens of investors.


Western Areas On The Compass

Oct 24 2011 - Australia

Western Areas delivered solid nickel production in the September quarter but whereto the nickel price?


The Oil Price, Libya And The Brent-WTI Spread

Oct 24 2011 - Commodities

Forex.com’s Kathleen Brooks offers a ‘fundamental’ outlook on the price of crude oil.


Iron Ore Prices Under Pressure

Oct 24 2011 - Commodities

Iron ore prices have continued to come under pressure in recent weeks and no sustained rally is expected before macroeconomic conditions stabilise.


Barclays Sees Oil At US$115 Per Barrel In 2012

Oct 24 2011 - Commodities

In the view of Barclays Capital the global oil market continues to tighten, which should support prices prices averaging US$115 per barrel in 2012.


Top Ten Weekly Recommendation, Target Price, Earnings Forecast Changes

Oct 24 2011 - FYI

Weekly update on recommendation, target price, and earnings forecast changes.


Your Editor On BoardRoomRadio

Oct 22 2011 - FYI

Your Editor participated in Friday’s Afternoon Round Table on brr.com.au


Neuren Pharma Could Be The Only One

Oct 21 2011 - Small Caps

The lead compound of Neuren Pharmaceuticals is being developed to treat brain injuries and with no current competition in the market Bell Potter sees upside from any success.


It’s Just Like Punting On Horses

Oct 21 2011 - FYI

FNArena welcomes Peter Switzer from Switzer TV and the Switzer Super Report as a regular columnist/contributor from today onwards.


Your Editor On Twitter

Oct 21 2011 - FYI

This week’s Tweets from Your Editor on Twitter.


Analyse The Market From A Different Angle